Ascelia Pharma (Sweden) Today
| ACE Stock | SEK 3.18 0.01 0.31% |
Performance12 of 100
| Odds Of DistressOver 53
|
Ascelia Pharma is selling for under 3.18 as of the 18th of January 2025; that is 0.31% down since the beginning of the trading day. The stock's last reported lowest price was 3.1. Ascelia Pharma has 53 percent odds of going through some form of financial distress in the next two years but had a very good returns during the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Ascelia Pharma AB operates as an oncology focused specialty pharmaceutical company that develops medicines to enhance the life expectancy for people living with cancer and cancer-related diseases in Sweden and Denmark. The company was founded in 2000 and is headquartered in Malm, Sweden. The company has 33.67 M outstanding shares. More on Ascelia Pharma AB
Moving together with Ascelia Stock
Moving against Ascelia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Ascelia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ascelia Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ascelia Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Ascelia Pharma AB (ACE) is traded on Stockholm Exchange in Sweden and employs 21 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 483.48 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ascelia Pharma's market, we take the total number of its shares issued and multiply it by Ascelia Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ascelia Pharma AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 33.67 M outstanding shares.
Ascelia Pharma AB has accumulated about 219.15 M in cash with (116.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Ascelia Pharma Probability Of Bankruptcy
Ownership AllocationAscelia Pharma holds a total of 33.67 Million outstanding shares. Ascelia Pharma AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ascelia Ownership Details
Ascelia Pharma AB Risk Profiles
Although Ascelia Pharma's alpha and beta are two of the key measurements used to evaluate Ascelia Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.13 | |||
| Semi Deviation | 2.23 | |||
| Standard Deviation | 4.2 | |||
| Variance | 17.65 |
Ascelia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ascelia Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Ascelia Pharma Corporate Management
Elected by the shareholders, the Ascelia Pharma's board of directors comprises two types of representatives: Ascelia Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ascelia. The board's role is to monitor Ascelia Pharma's management team and ensure that shareholders' interests are well served. Ascelia Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ascelia Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carl MD | Chief Officer | Profile | |
| Julie Brogren | Deputy Officer | Profile | |
| Magnus Corfitzen | Chief Officer | Profile | |
| Despina Hedin | Chief Officer | Profile | |
| Mikael Widell | Head Communications | Profile | |
| Andreas Norlin | Chief Officer | Profile |
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.